ABOUT US
Innovative Solutions
With our innovative and advanced bio-electric drug deposition technology, we strive to mitigate the adverse effects of pharmaceuticals and implants. Founded in 2012, our incredible team of innovators and engineers have worked tirelessly to drive Hydra Vascular to the forefront of intervention medicine. We continue to work relentlessly to improve drug delivery, absorption and efficacy for the best patient outcomes.
Get in touch to learn more.
WHAT WE DO
At Hydra Vascular, we believe that our bioelectronic solutions (otherwise known as SPARx) for mitigating vascular implants will soon become the standard of practice. We’ve only just started, but we've been skilled in developing many approved predicate products that are in clinical use today. Applying our skills and knowledge of basic and life sciences we continue to find new ways to bring better an more practical solutions for improving your quality of life.
​
Developing solutions for Cardiovascular, Peripheral and Neurovascular applications, Hydra Vascular intends to lead the industry for intervention therapies. Our focus is on returning body to its natural condition.
OUR TECHNOLOGY
Changing the Game
Our technology uses electrical energy to safely deposit a dose specific drug directly into the intended target tissue. We use energy to momentarily permeate the tissue with the pharmaceutical agent in a secure localized way. Because the drug stays localized to the diseased tissue, it is highly effective at low concentrations and mitigates systemic side effects. Imagine tattooing a drug into the intended tissue without a needle and with just a touch.
NEWS
HYDRA VASCULAR AWARDED USPTO PATENT
March 1, 2021
PRE-CLINICAL TAKEAWAYS: SUCCESSFUL ANIMAL DATA MEETS MILESTONE TIME POINT
August 15, 2021
August 1, 2022